67390 Courses

Level 5 Diploma | FREE QLS Endorsed Certificate | 10 CPD Courses & PDF Certificates | 170 CPD Points| Lifetime Access

Level 5 QLS Course With QLS Endorsed Certificate | 11 CPD Courses & PDF Certificates | 160 CPD Points | CPD Accredited

Level 4 QLS Diploma | FREE QLS Endorsed Certificate | 10 CPD Courses & Certificates | 220 CPD Points | CPD Accredited

This eLearning course is suitable to refresh your DSL training every 2 years for you and your safeguarding team.

This course will show you how to create a professional and attractive user interface (UI) in Django for data science using the Semantic UI framework.

Silver Clay Jewellery Class for Beginners. Have fun, learn new skills, and socialise in this beginner’s class! Learn how to create beautiful, hallmark quality sterling silver clay pendants and take home your handmade unique necklace.

This module describes the requirements that must be met to obtain licensure of a biological product. Subjects covered include the regulatory context, the content and format of the BLA submission, the review process, and provisions for expedited development and review.

Before equipment can be used routinely in production, it must first be commissioned and, if necessary, undergo Installation Qualification (IQ). This module describes commissioning and IQ requirements and procedures in the medicines and healthcare products industries. It follows the activities of a typical validation team as they carry out a project for a pharmaceutical company.

Manufacturers of medicines and healthcare products must establish, validate and maintain an equipment cleaning programme. This is a regulatory requirement because validated cleaning procedures contribute to the assurance of product purity and safety. This module provides a comprehensive account of equipment cleaning validation requirements and procedures. It follows the work of a pharmaceutical company's validation team as they establish and validate the cleaning program for a new production line.

Changes to the terms of marketing authorisations for medicinal products, called variations in Europe, must be notified to or approved by the relevant regulatory authorities. Variations include changes to the composition of products, their manufacturing processes, the way they are used, or the indications for which they are authorised. Common approaches are adopted within the European Economic Area to variations to marketing authorisations approved through the Centralised, Decentralised or Mutual Recognition Procedures. Recent legislation has substantially modified the regulatory requirements and extended them to purely national authorisations by member states. This module, which is fully up to date with the new legislation, covers the classification of variations into their several types and the regulatory requirements, guidance and procedures to be followed for each type.